Distinction between normal and renal cell carcinoma kidney cortical biopsy samples using pattern recognition of 1H magic angle spinning (MAS) NMR spectra

NMR in Biomedicine

Volumn 13, Issue 2, 2000, Pages 64-71

  Tate, A Rosemary ^a   Foxall, Peta J D ^b   Holmes, Elaine ^a   Moka, Detlef ^c   Spraul, Manfred ^d   Nicholson, Jeremy K ^a   Lindon, John C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Bruker Analytik GmbH   (Germany)

Author keywords

Kidney; MAS; NMR; Pattern recognition; Tumour

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC IMAGING; DISCRIMINANT ANALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY CORTEX; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR DIAGNOSIS;

EID: 0034066473     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(200004)13:2<64::AID-NBM612>3.0.CO;2-X     Document Type: Article

References (32)

1. Fossel ET, Carr JM, McDonagh J. Detection of malignant tumours - water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. New Engl. J. Med. 1986; 315: 1369-1376.
2. Engan T, Krane J, Kvinnsland S. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and ageing. NMR Biomed. 1991; 4: 142-149.
3. Mountford CE, Holmes KT, Mackinnon WB, Wright LC. Magnetic Resonance Spectroscopy of Biofluids, a New Tool in Clinical Biology, de Certaines JD (ed). World Scientific: Singapore, 1989; 103-120.
4. IH MRS spectra from brain tumours. NMR Biomed. 1998; 11: 177-191.
5. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL. Accurate, noninvasive diagnosis of human brain tumours by using proton magnetic resonance spectroscopy. Nature Med. 1996; 2: 323-325.
6. Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magn. Reson. Med. 1995; 34: 242-252.
7. IH magnetic resonance spectroscopic metabolic phenotypes. Neuroreport 1996; 7: 1597-1600.
8. IH nuclear magnetic resonance spectra by the application of chemometric techniques. Magn. Reson. Med. 1992; 28: 214-236.
9. IH NMR spectra from perchloric acid extracts of human brain tumour biopsies. Magn. Reson. Med. 1998; 39: 869-877.
10. IH MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Magn. Reson. Med. 1997; 38: 569-576.
11. IH nuclear magnetic resonance spectroscopy of intact kidney tissue samples. Anal. Commun. 1997; 34: 107-109.
12. IH nuclear magnetic resonance spectroscopy. J. Pharm. Biomed. Anal. 1998; 17: 125-132.
13. IH NMR analysis of intact prostatic hyperplastic and tumour tissues. Anal. Commun. 1998; 35: 113-115.
14. Cheng LL, Lean CL, Bogdanova A, Carter-Wright Jr. S, Ackerman JL, Brady TJ, Garrido L. Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle-spinning. Magn. Reson. Med. 1996; 36: 653-658.
15. IH HR MAS spectroscopy of intact biopsy samples improves assignment of peaks in vivo. Poster W1612, 6th International Meeting, ISMRM, Sydney, Australia, 1998.
16. I3C NMR spectroscopy of human blood plasma. Anal. Chem., 1995; 67: 793-811.
17. Nicholson JK, Flynn MP, Sadler PJ, MacLeod AF, Juul SM, Sonksen PH. Proton nuclear magnetic resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem. J. 1984; 217: 3565-3575.
18. Foxall PJD, Price RG, Jones JK, Neild GH, Thompson FD, Nicholson JK. High resolution proton magnetic resonance spectroscopy of cyst fluid from patients with polycystic kidney disease. Biochim. Biophys. Acta 1992; 1138: 305-314.
19. IH NMR spectroscopy of biological fluids and the investigation of perturbed metabolic processes. Special Publication, Royal Society of Chemistry. 157 Magnetic Resonance in Food Science 1995; 177-190.
20. Foxall PJD, Lenz EM, Lindon JC, Neild GH, Wilson ID. Nicholson JK. NMR and HPLC-NMR studies on the toxicity and metabolism of ifosfamide. Thera. Drug Monitor. 1996; 18: 498-505.
21. Ghauri FYK, Nicholson JK, Sweatman BC, Beddell CR, Lindon JC. NMR spectroscopy of human post mortem CSF: distinction of Alzheimer's disease from controls using pattern recognition and statistics. NMR Biomed. 1993; 6: 163-167.
22. IH NMR spectra of human urine from normal and pathological states. Anal. Biochem., 1994; 220: 284-296.
23. Anthony ML, Sweatman BC, Beddell CR, Lindon JC, Nicholson JK. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol. Pharmac. 1994; 46: 199-211.
24. IH NMR spectroscopy characterisation of the complex metabolic pattern of urine from patients with inborn errors of metabolism: 2-hydroxyglutaric aciduria and maple syrup urine disease. J. Pharm. Biomed. Anal. 1997; 15: 1647-1659.
25. SPSSX User's Guide, 3rd edition, SPSS Inc., Chicago, IL (1987).
26. Tate AR. Statistical pattern recognition for the analysis of biomedical magnetic resonance spectra. J. Magn. Reson. Anal. 1997; 3: 63-78.
27. McLachlan GJ. Discriminant Analysis and Statistical Pattern Recognition. Wiley, New York (1992).
28. Everitt BS, Dunn G. Applied Multivariate Data Analysis. Edward Arnold: London, 1991.
29. Norusis MJ. S.P.S.S. Advanced Statistics: Release 6.1. SPSS Inc.: Chicago, IL, 1994.
30. 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers. Anticancer Res. 1996; 16: 1587-1594.
31. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of brain tumours - an in vitro study. Neurosurgery 1994; 35: 606-613.
32. I3C NMR spectra using statistical pattern recognition and wavelets. Magn. Reson. Med. 1996; 35: 834-840.